Press Releases

    • NOV 21 2014

    Oncoceutics Initiates Collaborations with Fox Chase Cancer Center

    Hummelstown, PA (November 7, 2014) – Oncoceutics, Inc., announces the initiation of multifaceted preclinical collaborations with Fox Chase Cancer Center on its lead compound ONC201. These programs are supported in part by an NIH RO1 grant to study the mechanism of action of the first-in-class ONC201 anti-cancer drug candidate that was awarded to Wafik El-Deiry,

    • NOV 06 2014

    Oncoceutics Opens Office at University City Science Center

    Hummelstown, PA (November 4, 2014) – Oncoceutics, Inc., announces the expansion of its operations with the opening of an office at the University City Science Center in Philadelphia. The new office space will support the growth of its team as it transitions to a clinical stage company with multiple development programs. The company’s lead compound